Home Tags Antares Pharma

Tag: Antares Pharma

Are Analysts Turning Critical? – Antares Pharma, Inc. (ATRS), E*TRADE Financial...

Antares Pharma, Inc. (NASDAQ:ATRS) attracted a higher number of shares in volume with 3.53 million contracts traded on 10-Oct-18. However, its trading capacity stayed...

Cheap or Expensive Right Now? – Antares Pharma, Inc. (ATRS), HollyFrontier...

Antares Pharma, Inc. (NASDAQ:ATRS)'s price-to-sales ratio of 295.44 is creating a long-term opportunity in the value in its stock. The broad Medical Instruments &...

Technical Roundup On Two Stocks – Antares Pharma, Inc. (ATRS), Ascena...

Antares Pharma, Inc. (NASDAQ:ATRS) recently saw its volume around 1.6 million shares and on average it trades 1.52 million shares a day. The opening...

What The Market Is Missing About Barrick Gold Corporation (ABX), Antares...

Volume for Barrick Gold Corporation (NYSE:ABX) increased on 10/04/18 and the net result is a 0.03 gain from the open. The stock closed with...

Take Control Over How Stocks Move: Microsoft Corporation (MSFT), Antares Pharma,...

Microsoft Corporation (NASDAQ:MSFT) was less active in the last trading session as around 16.04 million shares exchanged hands on Wall Street, representing a decrease...

Investors Feeling Jittery About Antares Pharma, Inc. (ATRS), MiMedx Group, Inc....

Antares Pharma, Inc. (NASDAQ:ATRS) attracted a higher number of shares in volume with 11.3 million contracts traded on 02-Oct-18. However, its trading capacity stayed...

Antares Pharma, Inc. (ATRS) added to 15 new portfolios

Antares Pharma, Inc. (NASDAQ:ATRS) produced a 106.33% rally since recording the worst price of $1.58. Thanks to the latest -2.98% decrease, it now trades...

Analyst Views On Top Movers In Recent Trade: Antares Pharma, Inc....

Antares Pharma, Inc. (NASDAQ:ATRS) notched a 0.3% intraday gain moving at $3.36. When the opening bell rang, the price was $3.37. The number of...

Better Buy Than Competitors? – Antares Pharma, Inc. (ATRS), Sempra Energy...

Antares Pharma, Inc. (NASDAQ:ATRS) is simply too expensive to pass with a price-to-sales ratio of 270.16. The competitors from Medical Instruments & Supplies hold...

Summary of Analyst Ratings Tips: Clovis Oncology, Inc. (CLVS), Antares Pharma,...

The opening price for Clovis Oncology, Inc. (NASDAQ:CLVS) was $32.51 and the volume amounted to 2.76 million shares which compares with the average...